Sebika HCT Tablet 5/40/12.5 mg

Adult dose

This medication is taken once daily, one tablet, with water, irrespective of meals. It is recommended to take it at the same time each day (e.g., morning). The maximum dosage is Olmesartan/Amlodipine Medoxomil/Hydrochlorothiazide 10/40/25 mg. The recommended dosages are as follows: - 5/20/12.5 mg: Used for patients whose blood pressure is not adequately controlled with the Amlodipine/Olmesartan Medoxomil combination of 5/20 mg.

Child dose

The safety and efficacy of this medication for pediatric patients under 18 years have not been established, therefore its use is not recommended.

This medication should not be used during the second and third trimesters of pregnancy as it can cause serious damage to the fetus and newborn. If pregnancy is confirmed, treatment should be stopped immediately. Patients with allergies or hypersensitivity to any of the ingredients in this medication or similar drugs should not use it. It is also not recommended for pregnant or breastfeeding women, patients with severe hypotension, acute cardiac problems, or severe impairment of kidney or liver function. Patients with decreased blood volume or electrolyte imbalances may experience side effects such as hypotension when starting this medication, therefore they should be closely monitored. Patients who depend on kidney function or have liver dysfunction should also be administered with caution, and regular blood tests may be required to monitor kidney and electrolyte status as necessary. This medication has a blood pressure lowering effect, which may cause dizziness or lightheadedness, therefore driving or operating hazardous machinery should be approached with caution. During the use of this medication, be aware of interactions with other drugs, particularly when used with lithium, non-steroidal anti-inflammatory drugs (NSAIDs), or other antihypertensives; it is essential to follow the doctor's instructions. This drug may cause photosensitivity reactions, so excessive sun exposure should be avoided, and any rashes or itching should be reported to healthcare professionals immediately. Women who are pregnant or planning to become pregnant should avoid using this medication; it is also recommended not to use this medication while breastfeeding. While taking this medication, regular tests for blood pressure, kidney function, and electrolyte levels should be conducted to check for abnormalities, and if any unusual symptoms develop, consult a healthcare professional immediately. In case of overdose, symptoms may include hypotension, palpitations, dizziness, etc. If these symptoms occur, visit a medical institution immediately for appropriate treatment. This medication is not recommended for children or adolescents under 18 years of age as safety and effectiveness have not been established. In elderly patients, the dose should be adjusted and administered cautiously, particularly if there is decreased liver or kidney function.

Serious side effects

Urticaria, severe swelling (edema), difficulty breathing, dyspnea, pulmonary edema, jaundice, liver abnormalities (jaundice), sudden and severe headache, seizures, confusion, vision abnormalities, paralysis, acute renal failure, severe edema accompanied by elevated blood pressure, thrombocytopenia, anaphylactic reactions, vasculitis (including necrotizing vasculitis), thrombosis, embolism, acute interstitial pneumonia, acute respiratory distress syndrome (ARDS), Quincke's edema, Stevens-

Mild side effects

• Peripheral edema
• headache
• dizziness
• upper respiratory infections
• nasopharyngitis
• urinary tract infections
• sialadenitis
• leukopenia
• thrombocytopenia
• bone marrow suppression

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, preferably at room temperature between 1 and 30 degrees Celsius.

Appearance

Pale yellow round film-coated tablet

Package unit

28 tablets (14 tablets/PTP X 2)/carton